Niacin and Niacinamide Market 2027 by Form, End User and Geography | The Insight Partners

Niacin and Niacinamide Market to 2027 - Global Analysis and Forecasts By Form (Granular, Powder, Liquid); End User (Pharmaceuticals, Cosmeceuticals, Human Nutrition, Animal Nutrition) and Geography

Report Code: TIPRE00006879 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Niacin also referred to as vitamin B3, is an essential human nutrient. Niacin plays an important role in lowering cholesterol levels in human body which further lowers the risks of cardiovascular diseases. Studies have proved that niacin can boost the level of good HDL cholesterol and reduce the levels of triglycerides. Niacinamide is other form of vitamin B3 which is consumed to treat conditions like diabetes, oral cancer, acne, osteoarthritis, and other conditions. Niacin and niacinamide can together treat pellagra.

MARKET DYNAMICS

The niacin and niacinamide market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of chronic diseases like diabetes, cancer and others acne, acne and increasing incidences of childhood obesity. Furthermore, increasing government's initiatives for spreading awareness about benefits offered by niacin and niacinamide is likely to pose growth opportunities for the niacin and niacinamide market to grow.

MARKET SCOPE


The "Global Niacin and niacinamide market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of niacin and niacinamide market with detailed market segmentation by form and end user and geography. The global niacin and niacinamide market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading niacin and niacinamide market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION


The global niacin and niacinamide market is segmented on the basis of form and end user. Based on form, the market is segmented into granular, powder and liquid. Based on end user the market is segmented into pharmaceuticals, cosmeceuticals, human nutrition, animal nutrition and others.


REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global niacin and niacinamide market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The niacin and niacinamide market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting niacin and niacinamide market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the niacin and niacinamide market in these regions.


MARKET PLAYERS


The reports cover key developments in the niacin and niacinamide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from niacin and niacinamide market are anticipated to lucrative growth opportunities in the future with the rising demand for niacin and niacinamide market in the global market. Below mentioned is the list of few companies engaged in the niacin and niacinamide market.

The report also includes the profiles of niacin and niacinamide market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Merck KGaA
  •  Lonza Group AG
  •  DSM
  •  Evonik Industries
  •  Zhejiang NHU Co Ltd
  •  Vertellus Specialties UK
  •  Jubilant Life Sciences
  •  Fagron
  •  Brother Enterprises
  •  Bactolac Pharmaceutical Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Niacin and Niacinamide Market - By Form
1.3.2 Niacin and Niacinamide Market - By End User
1.3.3 Niacin and Niacinamide Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. NIACIN AND NIACINAMIDE MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. NIACIN AND NIACINAMIDE MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NIACIN AND NIACINAMIDE MARKET - GLOBAL MARKET ANALYSIS

6.1. NIACIN AND NIACINAMIDE - GLOBAL MARKET OVERVIEW
6.2. NIACIN AND NIACINAMIDE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NIACIN AND NIACINAMIDE MARKET - REVENUE AND FORECASTS TO 2027 - FORM

7.1. OVERVIEW
7.2. FORM MARKET FORECASTS AND ANALYSIS
7.3. GRANULAR
7.3.1. Overview
7.3.2. Granular Market Forecast and Analysis
7.4. POWDER
7.4.1. Overview
7.4.2. Powder Market Forecast and Analysis
7.5. LIQUID
7.5.1. Overview
7.5.2. Liquid Market Forecast and Analysis

8. NIACIN AND NIACINAMIDE MARKET - REVENUE AND FORECASTS TO 2027 - END USER

8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. PHARMACEUTICALS
8.3.1. Overview
8.3.2. Pharmaceuticals Market Forecast and Analysis
8.4. COSMECEUTICALS
8.4.1. Overview
8.4.2. Cosmeceuticals Market Forecast and Analysis
8.5. HUMAN NUTRITION
8.5.1. Overview
8.5.2. Human Nutrition Market Forecast and Analysis
8.6. ANIMAL NUTRITION
8.6.1. Overview
8.6.2. Animal Nutrition Market Forecast and Analysis

9. NIACIN AND NIACINAMIDE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Niacin and Niacinamide Market Overview
9.1.2 North America Niacin and Niacinamide Market Forecasts and Analysis
9.1.3 North America Niacin and Niacinamide Market Forecasts and Analysis - By Form
9.1.4 North America Niacin and Niacinamide Market Forecasts and Analysis - By End User
9.1.5 North America Niacin and Niacinamide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Niacin and Niacinamide Market
9.1.5.1.1 United States Niacin and Niacinamide Market by Form
9.1.5.1.2 United States Niacin and Niacinamide Market by End User
9.1.5.2 Canada Niacin and Niacinamide Market
9.1.5.2.1 Canada Niacin and Niacinamide Market by Form
9.1.5.2.2 Canada Niacin and Niacinamide Market by End User
9.1.5.3 Mexico Niacin and Niacinamide Market
9.1.5.3.1 Mexico Niacin and Niacinamide Market by Form
9.1.5.3.2 Mexico Niacin and Niacinamide Market by End User
9.2. EUROPE
9.2.1 Europe Niacin and Niacinamide Market Overview
9.2.2 Europe Niacin and Niacinamide Market Forecasts and Analysis
9.2.3 Europe Niacin and Niacinamide Market Forecasts and Analysis - By Form
9.2.4 Europe Niacin and Niacinamide Market Forecasts and Analysis - By End User
9.2.5 Europe Niacin and Niacinamide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Niacin and Niacinamide Market
9.2.5.1.1 Germany Niacin and Niacinamide Market by Form
9.2.5.1.2 Germany Niacin and Niacinamide Market by End User
9.2.5.2 France Niacin and Niacinamide Market
9.2.5.2.1 France Niacin and Niacinamide Market by Form
9.2.5.2.2 France Niacin and Niacinamide Market by End User
9.2.5.3 Italy Niacin and Niacinamide Market
9.2.5.3.1 Italy Niacin and Niacinamide Market by Form
9.2.5.3.2 Italy Niacin and Niacinamide Market by End User
9.2.5.4 Spain Niacin and Niacinamide Market
9.2.5.4.1 Spain Niacin and Niacinamide Market by Form
9.2.5.4.2 Spain Niacin and Niacinamide Market by End User
9.2.5.5 United Kingdom Niacin and Niacinamide Market
9.2.5.5.1 United Kingdom Niacin and Niacinamide Market by Form
9.2.5.5.2 United Kingdom Niacin and Niacinamide Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Niacin and Niacinamide Market Overview
9.3.2 Asia-Pacific Niacin and Niacinamide Market Forecasts and Analysis
9.3.3 Asia-Pacific Niacin and Niacinamide Market Forecasts and Analysis - By Form
9.3.4 Asia-Pacific Niacin and Niacinamide Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Niacin and Niacinamide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Niacin and Niacinamide Market
9.3.5.1.1 Australia Niacin and Niacinamide Market by Form
9.3.5.1.2 Australia Niacin and Niacinamide Market by End User
9.3.5.2 China Niacin and Niacinamide Market
9.3.5.2.1 China Niacin and Niacinamide Market by Form
9.3.5.2.2 China Niacin and Niacinamide Market by End User
9.3.5.3 India Niacin and Niacinamide Market
9.3.5.3.1 India Niacin and Niacinamide Market by Form
9.3.5.3.2 India Niacin and Niacinamide Market by End User
9.3.5.4 Japan Niacin and Niacinamide Market
9.3.5.4.1 Japan Niacin and Niacinamide Market by Form
9.3.5.4.2 Japan Niacin and Niacinamide Market by End User
9.3.5.5 South Korea Niacin and Niacinamide Market
9.3.5.5.1 South Korea Niacin and Niacinamide Market by Form
9.3.5.5.2 South Korea Niacin and Niacinamide Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Niacin and Niacinamide Market Overview
9.4.2 Middle East and Africa Niacin and Niacinamide Market Forecasts and Analysis
9.4.3 Middle East and Africa Niacin and Niacinamide Market Forecasts and Analysis - By Form
9.4.4 Middle East and Africa Niacin and Niacinamide Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Niacin and Niacinamide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Niacin and Niacinamide Market
9.4.5.1.1 South Africa Niacin and Niacinamide Market by Form
9.4.5.1.2 South Africa Niacin and Niacinamide Market by End User
9.4.5.2 Saudi Arabia Niacin and Niacinamide Market
9.4.5.2.1 Saudi Arabia Niacin and Niacinamide Market by Form
9.4.5.2.2 Saudi Arabia Niacin and Niacinamide Market by End User
9.4.5.3 U.A.E Niacin and Niacinamide Market
9.4.5.3.1 U.A.E Niacin and Niacinamide Market by Form
9.4.5.3.2 U.A.E Niacin and Niacinamide Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Niacin and Niacinamide Market Overview
9.5.2 South and Central America Niacin and Niacinamide Market Forecasts and Analysis
9.5.3 South and Central America Niacin and Niacinamide Market Forecasts and Analysis - By Form
9.5.4 South and Central America Niacin and Niacinamide Market Forecasts and Analysis - By End User
9.5.5 South and Central America Niacin and Niacinamide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Niacin and Niacinamide Market
9.5.5.1.1 Brazil Niacin and Niacinamide Market by Form
9.5.5.1.2 Brazil Niacin and Niacinamide Market by End User
9.5.5.2 Argentina Niacin and Niacinamide Market
9.5.5.2.1 Argentina Niacin and Niacinamide Market by Form
9.5.5.2.2 Argentina Niacin and Niacinamide Market by End User

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. NIACIN AND NIACINAMIDE MARKET, KEY COMPANY PROFILES

11.1. MERCK KGAA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. LONZA GROUP AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DSM
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. EVONIK INDUSTRIES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ZHEJIANG NHU CO LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. VERTELLUS SPECIALTIES UK
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JUBILANT LIFE SCIENCES,
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. FAGRON
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BROTHER ENTERPRISES
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BACTOLAC PHARMACEUTICAL INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Merck KGaA
2. Lonza Group AG
3. DSM
4. Evonik Industries
5. Zhejiang NHU Co Ltd
6. Vertellus Specialties UK
7. Jubilant Life Sciences
8. Fagron
9. Brother Enterprises
10. Bactolac Pharmaceutical Inc